Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRUKER CORPBRKR · Entity 3609 | President, BioSpin Group | February 24, 2017 | March 01, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRUKER CORP
Report date February 24, 2017 · Filed March 01, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,576 |
Reported balance
After 2017-02-24 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2017-02-24 · Exercise / conversion · Acquired 3,539 · Balance 14,576 |
| Common StockSEC Table I · non-derivative | Direct | 11,037 |
Reported balance
After 2017-02-24 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2017-02-24 · Sale · Acquired 3,539 · Balance 11,037 |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.46 · Expires 2025-12-01 | Direct | 10,620 |
Reported balance
After 2017-02-24 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-02-24 · Exercise / conversion · Disposed 3,539 · Balance 10,620 F1: The options vested in four approximately equal annual installments on the anniversary of the grant date, commencing on December 1, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vested in four approximately equal annual installments on the anniversary of the grant date, commencing on December 1, 2016.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2017 Filed Mar 1, 2017 19:26 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionStock option (right to buy) · Derivative | 3,539 | $0.00 Strike: $22.46 | $0.00 |
DisclosureSEC source: 0001179110-17-003456 · edgar.xml · derivative · entry 3 Lenggenhager Rene · CIK 0001658018 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,620 Underlying: Common Stock · 3,539 shares Expires 2025-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested in four approximately equal annual installments on the anniversary of the grant date, commencing on December 1, 2016. Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 19:26 UTC | BRUKER CORP BRKR · Entity 3609 | SaleCommon Stock | 3,539 | $23.93 | $84,677.30 |
DisclosureSEC source: 0001179110-17-003456 · edgar.xml · nonDerivative · entry 2 Lenggenhager Rene · CIK 0001658018 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,037 Read SEC document |
| February 24, 2017 Filed Mar 1, 2017 19:26 UTC | BRUKER CORP BRKR · Entity 3609 | Exercise / conversionCommon Stock | 3,539 | $22.46 | $79,485.94 |
DisclosureSEC source: 0001179110-17-003456 · edgar.xml · nonDerivative · entry 1 Lenggenhager Rene · CIK 0001658018 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:27 UTC | BRUKER CORP BRKR · Entity 3609 | GrantStock Option (Right to Buy) · Derivative | 17,942 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001179110-16-030519 · edgar.xml · derivative · entry 2 Lenggenhager Rene · CIK 0001658018 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,942 Underlying: Common Stock · 17,942 shares Expires 2026-10-04 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:27 UTC | BRUKER CORP BRKR · Entity 3609 | GrantCommon Stock | 5,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-030519 · edgar.xml · nonDerivative · entry 1 Lenggenhager Rene · CIK 0001658018 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,037 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.